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Abstract: Four new limonoids, dysohainanins A–D (1–4), and two new triterpenoids, dysohainanins E and F (5 and 6), together 
with seven known ones were isolated from the twigs and leaves of Dysoxylum hainanense Merr. The structures of the new  
compounds were determined by a variety of spectroscopic methods. The cytotoxic activities of these compounds were evaluated, 
and the known compound ent-19-nor-4,16,18-trihydroxy-8(14)-pomaren-15-one (13) showed in vitro cytotoxicity against HL-60, 
A-549, MCF-7, and SW480 cells, with IC50 values of 24.3, 28.1, 30.7, and 22.5 M, respectively. Compounds 2 and 3 were tested 
their insecticidal activities using brine shrimp and both of them were inactive. 
Keywords: Dysoxylum hainanense, Meliaceae, limonoids, triterpenoids, cytotoxicity 
Introduction 
The genus Dysoxylum has a number of structurally diverse 
limonoids with variety of bioactivities, such as anti-feeding, 
cardiac, cytotoxic, and anti-microbial activities1–7. D.  
hainanense is a tall tree distributed mainly in Guangxi Zhuang 
Autonomous Region, Hainan province, and southern part of 
Yunnan province in China. Previous efforts on D. hainanense 
have reported a series of antifeedant limonoids, antibacterial 
triterpenoids, and ent-pimarane diterpenoids6–14. As a part of 
our ongoing phytochemical investigation on plants of  
Meliaceae family, four new limonoids, dysohainanins A–D 
(1–4), and two new triterpenoids, dysohainanins E and F (5 
and 6), together with seven known ones (protoxylocarpin G 
(7)15, 22,23-epoxy-7-tirucalla-7-ene-3,24,25-triol (8)9, 20S,24-
epoxy-25,26,27-trisnor-24-oxo-3,4-seco-4(28)-dammaren-3-
oicacid (9)16, dysoxylumolide A (10)2, dysoxylumolide C (11)2, 
dysoxylumin C (12)2, ent-19-nor-4,16,18-trihydroxy-8(14)-
pomaren-15-one (13)9) were isolated from the twigs and leaves 
of D. hainanense. The structures of the new compounds were 
established on the basis of extensive 1D and 2D NMR  
experiments including 1H-1H COSY, HSQC, HMBC, and 
ROESY. The cytotoxic and insecticidal activities of these  































































































































*To whom correspondence should be addressed. E-mail: 
haoxj@mail.kib.ac.cn; lisl@mail.kib.ac.cn 
30      W. X. LIU et al.                                                                                                                           Nat. Prod. Bioprospect. 2012, 2, 29–34 
 
         
Results and Discussion 
Dysohainanin A (1) possessed the molecular formula of 
C37H50O13 deduced by the positive ion HRESIMS [m/z 
725.3133 [M + Na]+ (calcd. for 725.3149)] with 13 degrees of 
unsaturation. Absorption bands in its IR spectrum suggested 
obviously the presence of hydroxyl and carbonyl groups. The 
1D (see Tables 1 and 2) and 2D NMR data of 1 exhibited a 
methoxy group [C 52.4; H 3.70 (3H, s)], a 2-methyl-butyrate 
group [C 177.2 (qC, C-1'), 40.9 (CH, C-2'), 27.0 (CH2, C-3'), 
11.2 (CH3, C-4'), 16.5 (CH3, C-5'); H 2.36 (1H, m, H-2'), 1.50 
(1H, m, H-3'a), 1.38 (1H, m, H-3'b), 0.65 (3H, t, J = 7.4 Hz, 
H-4'), 1.07 (3H, d, J = 6.9 Hz, H-5')], and a 2-hydroxy-3-
methyl-butyrate group [C 175.1 (qC, C-1), 74.7 (CH, C-2), 
32.3 (CH, C-3), 15.7 (CH3, C-4), 19.2 (CH3, C-5); H 3.65 
(1H, br. s, H-2), 1.95 (1H, m, H-3), 0.79 (3H, d, J = 6.9 Hz, 
H-4), 0.96 (3H, d, J = 6.9 Hz, H-5)]. Except of the above 
mentioned substituents, compound 1 contained 26 carbons (see 
table 1) consisting of three tertiary methyls, three methylenes 
(including an oxygenated one), eight methines (including five 
oxygenated ones), four carbons indicated a typical -
substituted furan ring, two olefinic carbons, and other six  
quaternary carbons (including two carboyl one). These data 
suggested that 1 and dysoxylumic acid C 6 had the identical 
core structure, which was elucidated extensively by the 2D 
NMR data (see Fig. 1) of 1. The linkages of the methoxy 
group to C-3, the 2-methyl-butyrate group to C-16, and the 2-
hydroxy-3-methyl-butyrate group to C-12 were determined by 
the HMBC correlations of protons at H 3.70 (s, 3-OCH3) to C-
3 at C 170.9, proton at H 5.29 (dd, J = 9.4, and 0.5 Hz, H-16) 
to C-1' at C 177.2, and proton at H 5.65 (d, J = 7.5 Hz, H-12) 
to C-1at C 175.1, respectively. 
The relative stereochemistry of 1 was determined by its 
ROESY experiment. Correlations of H-11/Me-18, Me-18/H-
16, and H-15/H-16, Me-18/H-22, and Me-18/H-23 indicated 
that H-11, H-16, H-15, Me-18, and the -substituted furan ring 
were co-facial, and were arbitrarily assigned these groups a -
orientation, while 16-OR1, and H-17 was -oriented. The  
correlations of H-1/H-12, H-17/H-12, and Me-19/H-12 were 
deduced H-1, H-12, and Me-19 to be -orientation. Although 
there were no obvious cross-peaks of H-9 with other key  
protons in the ROESY spectrum, the -orientation of H-9 was 
determined by comparison of the NMR data with those of 
dysoxylumic acid C. So the structure of 1 was determined as 
shown and named as dysohainanin A. 
Table 1. 13C NMR data (1 in 150 MHz, 24 in 125 MHz) of 
14 (in CDCl3) 
poition 1 2 3 4
1 84.0, CH 73.1, CH 73.2, CH 79.7, CH 
2 35.2, CH2 35.3, CH2 35.7, CH2 37.5, CH2 
3 170.9, C 171.0, C 170.5, C 167.3, C 
4 89.5, C 91.3, C 91.4, C 79.0, C
5 42.6, CH 42.7, CH 42.7, CH 44.5, CH 
6 33.0, CH2 34.2, CH2 34.2, CH2 31.0, CH2 
7 175.3, C 175.1, C 175.3, C 170.9, C 
8 136.6, C 135.9, C 135.8, C 135.6, C 
9 50.0, CH 53.3, CH 53.2, CH 54.9, CH 
10 49.0, C 47.8, C 47.8, C 51.0, C 
11 79.4, CH 69.1, CH 68.9, CH 78.9, CH
12 79.3, CH 74.5, CH 74.6, CH 74.0, CH 
13 44.0, C 45.0, C 45.0, C 43.6, C 
14 70.5, C 68.9, C 68.9, C 69.6, C 
15 59.4, CH 58.8, CH 58.8, CH 58.9, CH 
16 76.9, CH 76.2, CH 76.2, CH 76.4, CH 
17 42.6, CH 42.2, CH 42.2, CH 42.1, CH 
18 15.7, CH3 14.9, CH3 14.9, CH3 14.7, CH3
19 19.2, CH3 16.2, CH3 16.2, CH3 17.2, CH3 
20 120.0, C 119.1, C 119.1, C 119.6, C 
21 141.2, CH 141.3, CH 141.3, CH 140.9, CH 
22 111.0, CH 110.8, CH 110.8, CH 110.9, CH 
23 143.3, CH 143.2, CH 143.2, CH 143.1, CH 
28 68.4, CH2 66.0, CH2 66.0, CH2 71.9, CH2 
29 20.3, CH3 19.0, CH3 19.0, CH3 26.5, CH3
30 121.7, CH2 123.6, CH2 123.7, CH2 121.7, CH2 
1′ 177.2, C 176.7, C 176.7, C 176.9, C 
2′ 40.9, CH 40.6, CH 40.6, CH 40.7, CH 
3′ 27.0, CH2 26.8, CH2 26.8, CH2 26.7, CH2 
4′ 11.2, CH3 10.9, CH3 10.9, CH3 10.9, CH3 
5′ 16.5, CH3 16.2, CH3 16.2, CH3 16.3, CH3 
1″ 175.1, C 174.6, C 174.6, C 175.0, C
2″ 74.7, CH 74.6, CH 74.5, CH 74.7, CH 
3″ 32.3, CH 31.2, CH 31.2, CH 32.1, CH 
4″ 15.7, CH3 19.0, CH3 19.0, CH3 15.6, CH3 
5″ 19.2, CH3 15.1, CH3 15.1, CH3 18.5, CH3 
11-OOCH  161.0, CH 160.9, CH  
3-OMe 52.4, CH3 52.2, CH3   
1-OAc 170.1, C 170.2, C 
  20.9, CH3 20.9, CH3  
3-OEt   61.1, CH2  




Fig. 1.  Selected HMBC and 1H-1H COSY correlations of 1 
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Dysohainanin B (2) was isolated as colorless crystal. The 
molecular formula of 2 was established as C40H54O16 by the 
positive HRESIMS ion at m/z 813.3309 [M + Na]+ (calcd. for 
813.3310) with 14 degrees of unsaturation. Comparison the 1H 
and 13C NMR data of 2 with those of 1 (see Tables 1 and 2) 
showed that 2 was very similar to dysohainanin A (1). The 
differences between them were that the five-membered oxygen 
ring formed through C-1 and C-11 was disappeared in 2  
instead of an acetyl group and a formyl group located at C-1 
(C 73.1) and C-11 (C 69.1), respectively. The two additional 
substituents supposed to link at C-1 and C-11 were further 
confirmed by the detail analysis of its 2D NMR spectra. 
The relative stereochemistry at the chiral centers of carbons 
C-9C-17 in 2 was determined as the same with 1 by the cross 
peaks observed in its ROESY spectrum. However, the stereo-
chemistry at the other chiral centers in 2 could not be  
determined by the ROESY experiment. Thus, the structure of 
2 was elucidated to be dysohainanin B as shown. 
Dysohainanin (3), a colorless crystal, had the molecular 
formula of C41H56O16 deduced by the positive ion HRESIMS. 
Detail analysis of its 1D NMR (see Tables 1 and 2) and MS 
data with those of 2 showed that an ethoxy group [C 61.1 
(CH2), 14.0 (CH3); H 4.13 (2H, m), 1.25 (3H, t, J = 7.2 Hz)] 
in 3 replaced the methoxy group located at C-1 in 2. The 
HMBC correlation of protons at H 4.13 (2H, m, -OCH2CH3) 
to carbon at C 170.5 (C-3) strongly suggested that the presence
of the ethoxy group was linked to C-3. The relative stereo-
chemistry of 3 was deduced as the same with 2 by analysis of 
its ROSEY spectrum. Therefore, the structure of 3 was  
established. 
Table 2. 1H NMR data (1 in 600 MHz, 24 in 500 MHz) of 1–4 in CDCl3 
position 1 2 3 4 
1 4.18, dd (10.6, 2.1) 5.60, d (11.4) 5.61, d (11.2) 4.05, dd (10.2. 5.6) 
2a 2.58, dd (14.3, 2.1) 2.95, d (15.5) 2.96, d (15.5) 2.95, dd (13.1, 5.6) 
2b 2.43, dd (14.3, 10.6) 2.55, dd (15.5, 11.4) 2.54, dd (15.5, 11.2) 2.75, dd (13.1, 10.2) 
5 2.82, d (10.0) 2.80, m 2.83, d (5.9) 2.37, t (9.2) 
6a 2.75, d (8.7) 2.77, m 2.79, d (16.9) 2.70, d (9.2) 
6b 2.60, m 2.44, dd (16.9, 5.6) 2.45, dd (16.9, 5.9) 2.63, d (9.2) 
9 3.51, d (9.6) 3.31, d (7.4) 3.32, d (7.3) 3.16, d (8.7) 
11 4.20, dd (9.6, 7.5) 5.45, m 5.46, m 4.15, m 
12 5.65, d (7.5) 5.87, d (11.0) 5.88, d (11.0) 5.56, d, (9.2) 
15 4.08, br. s 4.11, s 4.12, br. s 4.04, br. s 
16 5.29, dd (9.4, 0.5) 5.34, d (9.2) 5.35, d (9.2) 5.20, d (9.2) 
17 3.19, d (9.4) 3.14, d (9.2) 3.16, d (9.2) 3.03, d (9.2) 
18 0.87, s 1.06, s 1.08, s 0.84, s 
19 1.15, s 1.50, br. s 1.52, s 1.19, s 
21 7.12, s 7.14, s 7.16, s 7.06, s 
22 6.14, s 6.18, s 6.20, s 6.07, s 
23 7.32, s 7.33, br. s 7.35, s 7.27, s 
28a 3.53, d (12.6) 3.82, s 3.84, s 4.16, m 
28b 3.73, d (12.6)   3.92, d (11.2) 
29 1.47, s 1.61, s 1.63, s 1.57, s 
30a 5.42, s 5.55, s 5.56, s 5.48, s 
30b 5.38, s 5.37, s 5.39, s 5.33, s 
2′ 2.36, m 2.37, m 2.37, m 2.29, m 
3′a 1.50, m 1.48, m 1.49, m 1.42, m 
3′b 1.38, m 1.37, m 1.38, m 1.30, m 
4′ 0.65, t (7.4) 0.63, t (7.4) 0.62, t (7.4) 0.59, t (7.4) 
5′ 1.07, d (6.9) 1.10, d (6.9 ) 1.11, d (6.9) 1.00, d (6.9) 
2″ 3.65, br. s 3.45, br. s 3.47, s 3.61, s 
3″ 1.95, m 1.76, m 1.78, m 1.87, m 
4″ 0.79, d (6.9) 0.94, d (6.9) 0.96, d (6.9) 0.75, d (6.9) 
5″ 0.96, d (6.9 ) 0.73, d (6.9) 0.74, d (6.9) 0.91, d (6.9) 
11-OOCH  8.04, s 8.06, s  
3-OMe 3.70, s 3.67, s   
1-OAc  2.03, s 2.05, s  
3-OEt   4.13, m  
   1.25, t (7.2)  
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Dysohainanin D (4) had the molecular formula of C36H46O12 
on the basis of positive ion HRESIMS [m/z 693.2871 [M + 
Na]+ (calcd. for 693.2887)]. Its IR spectrum showed the pres-
ence of hydroxyl (3448 cm−1), and carbonyl (1743 cm−1) 
groups. The 1H NMR and 13C NMR spectra of 4 showed very 
similarity to those of dysoxylumolide A6, apart from a 2-
hydroxy-3-methyl-butyrate in dysoxylumolide A was replaced 
by a 2-methyl-butyrate group [1H-1H COSY correlations of 
proton at H 2.29 (m, H-2′) with proton at H 1.30 (m, H-3′b) 
and protons at H 1.00 (d, J = 6.9, H-5′), protons at H 0.59 (t, 
J = 7.4, H-4′) with proton at H 1.42 (m, H-3′a), together with 
the HMBC correlation of H-2′ to C 176.9 (C-1′)] in 4. The 
HMBC correlation of H 5.20 (d, J = 9.2, H-16) to C-1′  
suggested the 2-methyl-butyrate group was located at C-16. In 
the ROESY spectrum, the correlations of H-5/H-9, H-9/H-11, 
H-11/Me-18, Me-18/H-16 and H-16/H-15 revealed that H-5, 
H-9, H-11, H-15, H-16 and Me-18 possession the same  
configuration and were attributed as  configuration; on the 
contrary, H-1, H-12, H-17, Me-19 and Me-29 determined as  
configuration on the basis of literature and the correlations of 
H-1/H-12, H-12/ H-17, and Me-19/H-1. Hence, the structure 
of 4 was well established and named as dysohainanin D. 
The molecular formula of dysohainanin E (5) was deduced 
to be C32H50O6 by its HREIMS [m/z 530.3594 [M]+ (calcd. for 
530.3607)]. Analysis the 1H and 13C NMR data of 5 with those 
of turrapubesol B13 showed that 5 had the same skeleton type 
with the known compound with the exception of different  
substituents and number of double bonds. The 1H and 13C 
NMR data of 5 showed an acetyl group [H 1.94 (3H, s); C 
170.2, 21.2) instead of the phenylacetyl in turrapubesol B. 
Additionally, a downshift ketone carbonyl [C 216.9 (C-3)] 
together with two methylenes [C 38.8 (C-1), 33.9 (C-2)] in its 
1D NMR spectra suggested that the double bond between C-1 
and C-2 in the skeleton of turrapubesol B has been  
hydrogenated. The locations of the acetyl group and the absent 
double bond were further established by observed HMBC and 
1H-1H COSY correlations. The relative stereochemistry of 5 
was determined as the same with turrapubesol B by detailed 
analysis of its ROESY correlations together with comparison 
of their NMR data, and the  configuration of H-7 was  
deduced by the correlation of H-7/Me-30 in the ROESY  
spectrum. Therefore, the structure of 5 was established as 
dysohainanin E. 
Dysohainanin F (6), yellow powder, had the molecular  
formula of C30H48O3 by the HREIMS [m/z 456.3616 [M]+ 
(calcd. for 456.3603]. The 1H and 13C NMR data of 6 have a 
high similarity with 3,25-dihydroxy-tirucalla-7,23-dien7, only 
with the differences of C-3 and Me-26 in 6 oxidized to ketone 
carbonyl and hydroxymethyl, respectively, which was  
confirmed by the 2D NMR spectra. Compound 6 was  
determined and named as dysohainanin F. 
 
Experimental Section 
General Experimental Procedures. Melting points were 
determined using an X-4 melting point apparatus (Yingyu 
Yuhua Apparatus Factory, Gongyi, China) and were not  
corrected. Optical rotations were determined with a Perkin-
Elmer 241 polarimeter. IR spectra were recorded on a Bio-Rad 
FTS-135 spectrometer with a KBr disk. UV spectra were  
determined by Shimadzu UV2401PC. The 1H and 13C NMR 
spectra were recorded on a Bruker DRX-500 spectrometer, 
while 2D NMR spectra were recorded on Bruker Avance III 
Table 3. 1H NMR (500 MHz) and 13C NMR (125 MHz) data of 




δH δC δH δC 
1a 1.90, m 38.8, CH2 1.99, m 38.5, CH2 
1b 1.49, m  1.45, m  
2a 2.57, m 33.9, CH2 2.75, m 34.9, CH2 
2b 2.41, m  2.25, m  
3  216.9, C  217.0, C 
4  46.9, C  47.8, C 
5 1.83, m 48.2, CH 1.72, m 52.3, CH
6a 1.87, m 24.3, CH2 1.27, m 24.3, CH2 
6b 1.70, m  2.07, m  
7 5.20, dd,  
(1.9, 3.5) 
75.3, CH 5.30, d (3.0) 117.9, CH 
8  42.0, C  145.8, C 
9 2.00, m 43.0, CH 2.28, m 48.3, CH 
10  36.9, C  34.9, C
11a 1.67, m 16.7, CH2 1.55, m 18.2, CH2 
11b 1.55, m    
12a 2.26, m 34.8, CH2 1.82, m 33.6, CH2 
12b 1.55, m  1.65, m  
13  46.4, C  43.5, C 
14  159.2, C  51.2, C 
15a 5.29, d (2.7) 119.2, CH 1.48, m 33.9, CH2
15b   1.55, m  
16a 2.26, m 34.8, CH2 1.29, m 28.2, CH2 
16b 1.93, m  1.93, m  
17 1.97, m 52.2, CH 1.52, m 53.0, CH 
18 0.94, s 19.9, CH3 0.83, s 22.2, CH3 
19 1.01, s 15.2, CH3 1.00, s 12.7, CH3 
20 1.51, m 35.8, CH 1.48, m 36.0, CH 
21a 3.95, d (11.5) 70.0, CH2 0.82, d (5.4) 18.8, CH3 
21b 3.42, dd  
(11.5. 2.0) 
   
22a 2.00, m 36.3, CH2 2.36, m 38.1, CH2 
22b 1.51, m  1.69, m  
23 3.86, m 64.4, CH 5.70, dd  
(15.6, 7.9) 
129.5, CH 
24 2.87, d (9.0) 86.5, CH 5.46, d (15.6) 134.6,CH 
25  74.1, C  73.1, C 
26a 1.25, s 24.0, CH3 3.42, d (10.9) 70.0, CH2 
26b   3.49, d (10.9)  
27 1.29, s 28.5, CH3 1.26, s 24.4, CH3 
28 0.99, s 25.8, CH3 1.11, s 21.6, CH3 
29 1.01, s 20.9, CH3 1.04, s 24.5, CH3 
30 1.15, s 26.9, CH3 1.00, s 27.4, CH3 
7-OAc  170.2, C   
 1.94, s 21.2, CH3  
W. X. LIU et al.                                                                                                                           Nat. Prod. Bioprospect. 2012, 2, 29–34      33 
 
         
600 spectrometer. EIMS/ESIMS and HREIMS/HRESIMS 
spectra were measured with a Finnigan MAT 90 instrument 
and VG Auto Spec-3000 spectrometer, respectively. Prepara-
tive HPLC was performed on an Agilent column (i.d. 21.2  
150 mm, XDB-C18, Agilent, USA), developed with 
CH3OH:H2O or CH3CN:H2O (flow rate: 25.0 mL/min, detec-
tion: UV 230 nm) at 25 °C. Column chromatography was per-
formed on silica gel (90-150 μm; Qingdao Marine Chemical 
Inc.), MCI gel (CHP20P, 75-150 μm, Mitsubishi Chemical 
Industries Ltd.), C18 reversed-phase silica gel (20-45 μm; 
Merck, Darmstadt, Germany), and Sephadex LH-20 (40-70 μm; 
Amersham Pharmacia Biotech AB, Uppsala, Sweden). TLC 
plates were precoated with silica gel GF254 and HF254 (Qingdao 
Haiyang Chemical Plant, Qingdao, China). 
 
Plant Material. The twigs and leaves of D. hainanense 
were collected in Xishuangbanna, Yunnan Province, People’s 
Republic of China, and were identified by Prof. Xun Gong of 
Kunming Institute of Botany, Chinese Academy of Sciences 
(CAS). Voucher specimen (No. H20090901) was deposited in 
the State Key Laboratory of Phytochemistry and Plant Re-
sources in West China, Kunming Institute of Botany, CAS, 
Kunming, China. 
 
Extraction and Isolation. The powder of air-dried twigs 
and leaves of D. hainanense (24.0 kg) was extracted with 95% 
acetone (35 L  3) under reflux. The extracts were combined 
and then suspended in water, which was extracted with  
petroleum ether (PE, 10 L 3) and EtOAc (10 L  3)  
respectively. The EtOAc part (450 g) were subjected to  
column chromatography over repeated silica gel, MCI gel, 
Sephadex LH-20 and preparative HPLC to afford 1 (1.5 mg), 2 
(18.0 mg), 3 (17.0 mg), 4 (2.9 mg), 5 (17.0 mg), and 6 (11.0 
mg). (see details in Electronic Supplementary Material) 
 
Dysohainanin A (1): white powder; mp 145–147 °C; [α]11D   
–17.5 (c 0.12, CHCl3); IR (KBr): max 3439, 2957, 2924, 2853, 
1738, 1462, 1138, 1072 cm–1; for 1H NMR and 13C NMR, see 
Tables 1 and 2; positive ion HRESIMS m/z 725.3133 [M + 
Na]+ ( calcd. for C37H50O13Na, 725.3149). 
 
Dysohainanin B (2): colorless crystal; mp 159–161 °C; 
[α]17D   +62.1 (c 0.32, CHCl3); IR (KBr): max 3447, 2968, 1739, 
1177, 1143 cm–1; for 1H NMR and 13C NMR, see Tables 1 and 
2; positive ion HRESIMS: m/z 813.3309 [M + Na]+ ( calcd. for 
C40H54O16Na, 813.3310). 
 
Dysohainanin C (3): colorless crystal; mp 129–131 °C; 
[α]11D   +24.1 (c 0.16, CHCl3); IR (KBr): max 3440, 2959, 2923, 
1736, 1179, 1142 cm–1; for 1H NMR and 13C NMR, see Tables 
1 and 2; positive ion HRESIMS: m/z 827.3459 [M + Na]+ 
( calcd. for C41H56O16Na, 827.3466). 
 
Dysohainanin D (4): colorless crystal; mp 174–175 °C; 
[α]11D   –18.8 (c 0.08, CHCl3); IR (KBr): max 3448, 2957, 2923, 
2853, 1743, 1462, 1137, 1077 cm–1; for 1H NMR and 13C 
NMR, see Tables 1 and 2; positive ion HRESIMS: m/z 
693.2871 [M + Na]+ ( calcd. for C36H46O12Na, 693.2887). 
Dysohainanin E (5): white powder; mp 88–90 °C; [α]17D   –
34.7 (c 0.26, CHCl3); IR (KBr): max 3433, 2932, 1707, 1378, 
1247 cm–1; for 1H NMR and 13C NMR, see Table 3; HREIMS 
m/z 530.3594 [M]+ ( calcd. for C32H50O6, 530.3607). 
 
Dysohainanin F (6): yellow powder; mp 82–84 °C; [α]17D   –
28.7 (c 0.38, CHCl3); IR (KBr): max 3438, 2966, 2931, 1708, 
1460, 1385, 755 cm–1; for 1H NMR and 13C NMR, see Table 3; 
HREIMS m/z 456.3616 [M]+ ( calcd. for C30H48O3, 456.3603). 
 
Cytotoxicity Assay. The anti-tumor activity of 1, 5, 6, 10, 
11, and 13 against HL-60, SMMC-7721, A-549, MCF-7 and 
SW480 cell lines was determined by the MTT method18,  
compound 13 showed in vitro cytotoxicity against HL-60, 
SMMC-7721, A-549, MCF-7, and SW480 cell lines, with IC50 
values of 24.3, > 40, 28.1, 30.7, and 22.5 M, and the acetone 
crude extraction of D. hainanense with IC50 values of 36.9, 
40.6, 60.7, 44.0, and 36.7 g/mL, respectively, while com-
pounds 1, 5, 6, 10, and 11 have not shown in vitro cytotoxicity 
against these cell lines. (see details in Table 4). 
 
Insecticidal Assay. Compounds 2 and 3 have been test their 
insecticidal activity using brine shrimp at the concerntrations 
of 100, 50, 10 ppm. The result exbihited that they were  
inactive toward brine shrimp. 
 
Method for Insecticidal Test19. The test compounds were 
dissolved in DMSO or water and then diluted with artificial 
seawater to the final concentrations of 100, 50, 10 ppm (mg/L), 
which were added to 96-well plates with each well of 1525 
brine shrimps. After cultivation under 28 °C for 24 h, the 
numbers of the dead brine shrimps were counted with a micro-
scope. Each concentration was repeated in triplicate, and the 
control group was treated in the same way without samples. 
Mortality = (the mortality of the brine shrimps with sample 
 the mortality of the brine shrimps of control group) / (1  the 
mortality of the brine shrimps of control group)  100% 
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Supplementary material is available in the online version of 
this article at http://dx.doi.org/10.1007/s13659-011-0030-8 
and is accessible for authorized users. 
 
Table 4. Cytotoxicities (for compounds and extract IC50 in μM 
and μg/mL respectively) of compounds 1, 5, 6, 10, 11, 13, and 
the acetone extract of D. hainanense. 
Samples HL-60 SMMC-7721 A-549 MCF-7 SW480
1 > 40 > 40 > 40 > 40 > 40 
5 > 40 > 40 > 40 > 40 > 40 
6 > 40 > 40 > 40 > 40 > 40 
10 > 40 > 40 > 40 > 40 > 40 
11 > 40 > 40 > 40 > 40 23.5 
13 24.3 > 40 28.1 30.7 22.5 
extract 36.9 40.6 60.7 44.0 36.7
cis-platin 2.51 15.0 13.6 10.6 12.3 
taxol < 0.008 < 0.008 < 0.008 < 0.008 < 0.008
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